J. Nolta

M. Zern, S. Lingala, J. Nolta, 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells.

J. Nolta, M. Creer, W. Eades, 2006, Blood.

Artificial escape from XCI by DNA methylation editing of the CDKL5 gene

H. O'Geen, D. Segal, J. Nolta, 2020, Nucleic acids research.

Lysophosphatidic Acid Enhances Stromal Cell-Directed Angiogenesis

J. Nolta, J. K. Leach, B. Binder, 2013, PloS one.

“Next‐generation” mesenchymal stem or stromal cells for the in vivo delivery of bioactive factors: progressing toward the clinic

J. Nolta, 2016, Transfusion.

Fibroblast Growth Factor 2 Regulates High Mobility Group A2 Expression in Human Bone Marrow‐Derived Mesenchymal Stem Cells

J. Nolta, F. Fierro, Stefanos Kalomoiris, 2016, Journal of cellular biochemistry.

Ethanol Negatively Regulates Hepatic Differentiation of hESC by Inhibition of the MAPK/ERK Signaling Pathway In Vitro

M. Zern, P. Zhou, J. Nolta, 2014, PloS one.

shRNA-mediated decreases in c-Met levels affect the differentiation potential of human mesenchymal stem cells and reduce their capacity for tissue repair.

D. Link, J. Nolta, Ivana Rosová, 2010, Tissue engineering. Part A.

Enhancing Retention of Human Bone Marrow Mesenchymal Stem Cells with Prosurvival Factors Promotes Angiogenesis in a Mouse Model of Limb Ischemia.

J. Nolta, P. Zhou, W. Yao, 2019, Stem cells and development.

American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells.

K. Cornetta, M. Sadelain, C. A. Blau, 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass

K. Lam, R. Ritchie, R. Liu, 2012, Nature Medicine.

Mesenchymal stem cells for trinucleotide repeat disorders.

J. Nolta, G. Bauer, G. Annett, 2013, Methods in molecular biology.

Establishment and Transduction of Primary Human Stromal/Mesenchymal Stem Cell Monolayers

J. Nolta, G. Bauer, T. Meyerrose, 2006 .

Engineered BDNF producing cells as a potential treatment for neurologic disease

J. Nolta, G. Annett, Abigail S. Yu, 2016, Expert opinion on biological therapy.

A triterpene glycoside from black cohosh that inhibits osteoclastogenesis by modulating RANKL and TNFalpha signaling pathways.

S. Qiu, M. Gross, P. Zhou, 2007, Chemistry & biology.

Mesenchymal Stem/Stromal Cell Therapy Is More Cost-Effective Than Fecal Diversion for Treatment of Perianal Crohn’s Disease Fistulas

M. Dave, Sheeva Johnson, J. Nolta, 2022, Frontiers in Immunology.

Primed mesenchymal stem cells package exosomes with metabolites associated with immunomodulation.

O. Fiehn, P. Belafsky, Brian Fury, 2019, Biochemical and biophysical research communications.

Novel Targeted Therapy for Precursor B-Cell Acute Lymphoblastic Leukemia: Anti-CD22 Antibody-MXD3 Antisense Oligonucleotide Conjugate

L. Beckett, Shuling Guo, N. Satake, 2014, Molecular medicine.

Biology of umbilical cord blood progenitors in bone marrow niches.

C. Verfaillie, J. Nolta, M. Creer, 2007, Blood.

Effects on Proliferation and Differentiation of Multipotent Bone Marrow Stromal Cells Engineered to Express Growth Factors for Combined Cell and Gene Therapy

J. Nolta, F. Fierro, Claus Sondergaard, 2011, Stem cells.

Immunodeficient mouse models to study human stem cell-mediated tissue repair.

D. Link, P. Zhou, J. Nolta, 2008, Methods in molecular biology.

Human stem cells for tissue repair.

J. Nolta, D. Hess, P. Zhou, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Highly Efficient Differentiation of Endothelial Cells from Pluripotent Stem Cells Requires the MAPK and the PI3K Pathways

Aijun Wang, J. Nolta, P. Zhou, 2017, Stem cells.

Bone marrow mesenchymal stem cells provide an alternate pathway of osteoclast activation and bone destruction by cancer cells.

H. Shimada, Y. DeClerck, A. Erdreich-Epstein, 2005, Cancer research.

Crosstalk Between Adrenergic and Toll‐Like Receptors in Human Mesenchymal Stem Cells and Keratinocytes: A Recipe for Impaired Wound Healing

R. Isseroff, J. Nolta, M. Dasu, 2014, Stem cells translational medicine.

Developing stem cell for juvenile adult-onset Huntington's disease.

V. Wheelock, J. Nolta, Stewart, 2015 .

Genetically engineered stem cells as a proposed therapeutic for Huntington's disease.

V. Wheelock, J. Nolta, G. Bauer, 2012 .

Flavokawain B, the hepatotoxic constituent from kava root, induces GSH‐sensitive oxidative stress through modulation of IKK/NF‐κB and MAPK signaling pathways

S. Qiu, D. Piwnica-Worms, P. Zhou, 2010 .

Factors Affecting Human T Cell Engraftment, Trafficking and Associated Xenogeneic Graft-Versus-Host Disease in NOD/SCID

J. Dipersio, D. Piwnica-Worms, Hanlin L. Wang, 2008 .

Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull mice.

J. Dipersio, D. Piwnica-Worms, Hanlin L. Wang, 2007, Experimental hematology.

Immune-deficient mouse models for analysis of human stem cells.

J. Nolta, T. Meyerrose, D. Hess, 2003, BioTechniques.

Immunodeficient mice as models of human hematopoietic stem cell engraftment.

J. Nolta, M. Dao, 1999, Current opinion in immunology.

FLT3 ligand preserves the ability of human CD34+ progenitors to sustain long-term hematopoiesis in immune-deficient mice after ex vivo retroviral-mediated transduction.

C. Hannum, D. Kohn, J. Nolta, 1997, Blood.

Improved method to bridge mouse and man

J. Nolta, 2004 .

Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: analysis of gene transduction of long-lived progenitors.

D. Kohn, J. Nolta, M. B. Hanley, 1994, Blood.

The number and generative capacity of human B lymphocyte progenitors, measured in vitro and in vivo, is higher in umbilical cord blood than in adult or pediatric bone marrow

J. Nolta, F. Thiemann, J. Arakawa-Hoyt, 1999, Bone Marrow Transplantation.

Transduction of pluripotent human hematopoietic stem cells demonstrated by clonal analysis after engraftment in immune-deficient mice.

D. Kohn, J. Nolta, M. Dao, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Loss of MXD3 induces apoptosis of Reh human precursor B acute lymphoblastic leukemia cells.

K. Lam, N. Satake, J. Nolta, 2015, Blood cells, molecules & diseases.

P3C-2 Ultrasound Energy Rapidly Labels Stem/Progenitor Cells with Nanoparticle Beacons without Disrupting Membrane Integrity

J. Nolta, S. Wickline, G. Lanza, 2007, 2007 IEEE Ultrasonics Symposium Proceedings.

Autologous myoblasts attenuate atrophy and improve tongue force in a denervated tongue model: A pilot study

P. Belafsky, E. Plowman, D. Cates, 2014, The Laryngoscope.

Cutting Edge Advances in Stem Cell Biology and Therapy

J. Nolta, 2017, Stem cells.

Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor.

J. Dipersio, J. Nolta, S. Devine, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Immunosuppressive Activity of Adult Marrow Mesenchymal Stromal Cells on Innate Immune Cells in the Central Nervous System

C. Case, J. Nolta, M. Dao, 2013 .

Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution.

J. Nolta, J. Arevalo, M. Dao, 2003, Blood.

New Advances in Understanding Stem Cell Fate and Function

J. Nolta, 2015, Stem cells.

Cell-based therapies for coronavirus disease 2019: proper clinical investigations are essential

I. Martin, S. Viswanathan, M. Krampera, 2020, Cytotherapy.

Engineered BDNF producing cells as a potential treatment for Huntington ' s disease and other neurological indications

J. Nolta, G. Annett, Abigail S. Yu, 2016 .

Human Myoblast and Mesenchymal Stem Cell Interactions Visualized by Videomicroscopy

P. Belafsky, J. Nolta, K. Pepper, 2015, Human gene therapy methods.

Potential long-term treatment of hemophilia A by neonatal co-transplantation of cord blood-derived endothelial colony-forming cells and placental mesenchymal stromal cells

Aijun Wang, J. Nolta, P. Zhou, 2019, Stem Cell Research & Therapy.

Stem Cell Repor ts Electrical Guidance of Human Stem Cells in the Rat Brain

J. Nolta, B. Lyeth, Jiebei Jiang, 2017 .

Migration of mesenchymal stem cells to heart allografts during chronic rejection

V. Starnes, J. Nolta, M. Barr, 2003, Transplantation.

Cytokine and integrin stimulation synergize to promote higher levels of GATA-2, c-myb, and CD34 protein in primary human hematopoietic progenitors from bone marrow.

J. Nolta, M. Dao, 2007, Blood.

Upregulation of Runx2 and Osterix during in vitro chondrogenesis of human adipose-derived stromal cells.

J. Nolta, L. Sandell, Ivana Rosová, 2008, Biochemical and biophysical research communications.

Engineered extracellular vesicles with high collagen-binding affinity present superior in situ retention and therapeutic efficacy in tissue repair

Aijun Wang, Jian Jian Li, J. Nolta, 2022, Theranostics.

Widespread Nonhematopoietic Tissue Distribution by Transplanted Human Progenitor Cells with High Aldehyde Dehydrogenase Activity

P. Zhou, J. Nolta, M. Sands, 2008, Stem cells.

Isolation of Human CD34- Cells with High Aldehyde Dehydrogenase Activity Reveals a Novel Population with Hematopoietic Repopulating Potential.

J. Nolta, D. Hess, L. Wirthlin, 2004 .

Retroviral transfer of the glucocerebrosidase gene into CD34+ cells from patients with Gaucher disease: in vivo detection of transduced cells without myeloablation.

R. Schiffmann, S. Karlsson, R. Brady, 1998, Human gene therapy.

An in vivo Cell-Based Delivery Platform for Zinc Finger Artificial Transcription Factors in Pre-clinical Animal Models

H. O'Geen, U. Beitnere, J. Silverman, 2022, Frontiers in Molecular Neuroscience.

Retroviral-mediated transfer of the human glucocerebrosidase gene into cultured Gaucher bone marrow.

D. Kohn, J. Nolta, I. Bahner, 1992, The Journal of clinical investigation.

Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity.

J. Nolta, T. Meyerrose, M. Creer, 2004, Blood.

Expression of human glucocerebrosidase in murine long-term bone marrow cultures after retroviral vector-mediated transfer.

D. Kohn, J. Nolta, J. Barranger, 1990, Blood.

Mesenchymal stem versus stromal cells: International Society for Cellular Therapy Mesenchymal Stromal Cell committee position statement on nomenclature.

I. Martin, S. Viswanathan, M. Krampera, 2019, Cytotherapy.

Bone Marrow-Derived Aldehyde Dehdrogenase Expressing Cells Possess Endothelial Progenitor Function in Addition to Hematopoietic Repopulating Ability and Aid in Blood Flow Recovery after Acute Ischemic Injury.

D. Link, J. Nolta, Benjamin J. Capoccia, 2005 .

progenitors from bone marrow GATA-2, c-myb, and CD34 protein in primary human hematopoietic Cytokine and integrin stimulation synergize to promote higher levels of

J. Nolta, M. Dao, 2013 .

Safety and Efficacy of a tCD25 Preselective Combination Anti‐HIV Lentiviral Vector in Human Hematopoietic Stem and Progenitor Cells

B. Torbett, J. Nolta, G. Bauer, 2015, Stem cells.

Human cord blood progenitors with high aldehyde dehydrogenase activity improve vascular density in a model of acute myocardial infarction

Dustin J. Maxwell, D. Piwnica-Worms, J. Nolta, 2008, Journal of Translational Medicine.

In Vivo Distribution of Human Adipose‐Derived Mesenchymal Stem Cells in Novel Xenotransplantation Models

Daniel A. De Ugarte, J. Nolta, M. Sands, 2007, Stem cells.

Retroviral vector-mediated gene transfer into primitive human hematopoietic progenitor cells: effects of mast cell growth factor (MGF) combined with other cytokines.

D. Williams, G. Crooks, D. Kohn, 1992, Experimental hematology.

Revascularization of ischemic limbs after transplantation of human bone marrow cells with high aldehyde dehydrogenase activity.

Dustin J. Maxwell, D. Link, D. Piwnica-Worms, 2009, Blood.

Spotlight on hematopoietic stem cells: looking beyond dogma. Introduction.

J. Nolta, C. Jordan, 2001, Leukemia.

CD34: To select or not to select? That is the question

J. Nolta, M. Dao, 2000, Leukemia.

The gold standard improves: a better assay for HSCs

J. Nolta, C. Jordan, 2005 .

The oncogene LRF is a survival factor in chondrosarcoma and contributes to tumor malignancy and drug resistance.

P. D. Di Cesare, J. Nolta, Lalita Gupta, 2012, Carcinogenesis.

Long-term effects of intravitreal injection of GMP-grade bone-marrow-derived CD34+ cells in NOD-SCID mice with acute ischemia-reperfusion injury.

Susanna S. Park, M. Grant, J. Nolta, 2012, Investigative ophthalmology & visual science.

Long-Term Effects of Intravitreal Injection of GMP-Grade Bone-Marrow – Derived CD 34 Cells in NOD-SCID Mice with Acute Ischemia-Reperfusion Injury

Susanna S. Park, M. Grant, J. Nolta, 2012 .

Retroviral-mediated transduction and clonal integration analysis of human hematopoietic stem and progenitor cells.

J. Nolta, M. Dao, 2002, Methods in molecular medicine.

Human Hematopoietic Cell Culture, Transduction, and Analyses

D. Kohn, J. Nolta, 1997 .

NODAL inhibition promotes differentiation of pacemaker-like cardiomyocytes from human induced pluripotent stem cells

Dalyir I. Pretto, D. Lieu, J. Nolta, 2020, Stem cell research.

Hypoxic Preconditioning of Mesenchymal Stromal Cells Induces Metabolic Changes, Enhances Survival, and Promotes Cell Retention In Vivo

J. Nolta, R. Isseroff, J. Beegle, 2015, Stem cells.

Improving mesenchymal stem/stromal cell potency and survival: Proceedings from the International Society of Cell Therapy (ISCT) MSC preconference held in May 2018, Palais des Congrès de Montréal, Organized by the ISCT MSC Scientific Committee.

J. Galipeau, J. Nolta, D. Phinney, 2020, Cytotherapy.

Autoimmune T cells lured to a FASL web of death by MSCs.

J. Nolta, W. Murphy, 2012, Cell stem cell.

Phenotypic comparison of extrathymic human bone-marrow-derived T cells with thymic-selected T cells recovered from different tissues.

J. Nolta, M. Dao, X. Wang, 2001, Clinical immunology.

An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells Committee editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for coronavirus disease-19: time for a global registry

K. Tarte, M. Lalu, S. Viswanathan, 2022, Cytotherapy.

An ISCT MSC Committee Editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for COVID-19: Time for a global registry

K. Tarte, M. Lalu, S. Viswanathan, 2022, Cytotherapy.

Cell-based therapies for coronavirus disease 2019: proper clinical investigations are essential TaggedEnd

S. Viswanathan, M. Krampera, J. Galipeau, 2022 .

Analysis of the retinal capillary plexus layers in a murine model with diabetic retinopathy: effect of intravitreal injection of human CD34+ bone marrow stem cells

Susanna S. Park, N. Marsh-Armstrong, J. Nolta, 2020, Annals of translational medicine.

Concise Review: Induced Pluripotent Stem Cell‐Derived Mesenchymal Stem Cells: Progress Toward Safe Clinical Products

J. Nolta, G. Bauer, Yunjoon Jung, 2012, Stem cells.

Effects of Micronized Cartilage Matrix on Cartilage Repair in Osteochondral Lesions of the Talus

J. Nolta, Cassandra A. Lee, E. Giza, 2018, Cartilage.

The oromaxillofacial region as a model for a one-health approach in regenerative medicine.

N. Vapniarsky, B. Arzi, J. Nolta, 2022, American journal of veterinary research.

Endothelial cells derived from patients' induced pluripotent stem cells for sustained factor VIII delivery and the treatment of hemophilia A

G. Pan, Aijun Wang, J. Nolta, 2020, Stem cells translational medicine.

Mesenchymal stromal cells as gene delivery vehicles to treat nonmalignant diseases

J. Nolta, J. Beegle, F. Fierro, 2016 .

Combination product of dermal matrix, human mesenchymal stem cells, and timolol promotes diabetic wound healing in mice

J. Nolta, M. Dasu, A. Soulika, 2020, Stem cells translational medicine.

Clonality analysis after retroviral-mediated gene transfer to CD34+ cells from the cord blood of ADA-deficient SCID neonates

B. Aronow, M. Wissler, D. Kohn, 2003, Nature Medicine.

Companion animals: Translational scientist’s new best friends

Leigh G. Griffiths, Kyriacos A. Athanasiou, Robert B. Rebhun, 2015, Science Translational Medicine.

Involvement of mesenchymal stem cells in cancer progression and metastases.

J. Nolta, Jian Wu, A. Chang, 2015, Current cancer drug targets.

Mesenchymal stem/stromal cells genetically engineered to produce vascular endothelial growth factor for revascularization in wound healing and ischemic conditions

Brian Fury, J. Nolta, G. Bauer, 2018, Transfusion.

Lentiviral‐Transduced Human Mesenchymal Stem Cells Persistently Express Therapeutic Levels of Enzyme in a Xenotransplantation Model of Human Disease

J. Nolta, M. Sands, T. Meyerrose, 2008, Stem cells.

The Oncogene LRF Stimulates Proliferation of Mesenchymal Stem Cells and Inhibits Their Chondrogenic Differentiation

P. D. Di Cesare, J. Nolta, C. Acharya, 2013, Cartilage.

Generation of HIV-1 resistant and functional macrophages from hematopoietic stem cell-derived induced pluripotent stem cells.

Brian Fury, J. Nolta, G. Bauer, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Targeted therapy with MXD3 siRNA, anti‐CD22 antibody and nanoparticles for precursor B‐cell acute lymphoblastic leukaemia

David M. Rocke, N. Satake, J. Nolta, 2014, British journal of haematology.

Autologous Muscle‐Derived Cell Therapy for Swallowing Impairment in Patients Following Treatment for Head and Neck Cancer

P. Belafsky, N. Nativ-Zeltzer, J. Nolta, 2021, The Laryngoscope.

Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations.

M. Zern, S. Lingala, J. Nolta, 2011, Journal of hepatology.

Generation of human vascularized brain organoids

B. Waldau, J. Nolta, P. Zhou, 2018, Neuroreport.

Electrical Guidance of Human Stem Cells in the Rat Brain

Min Zhao, J. Nolta, B. Lyeth, 2017, Stem cell reports.

Comprehensive Proteomic Analysis of Mesenchymal Stem Cell Exosomes Reveals Modulation of Angiogenesis via Nuclear Factor‐KappaB Signaling

F. Chédin, J. Lehtiö, Brian Fury, 2016, Stem cells.

Novel Targeted Therapy for Neuroblastoma: Silencing the MXD3 Gene Using siRNA

L. Beckett, N. Satake, J. Nolta, 2017, Pediatric Research.

In vitro purging of human rhabdomyosarcoma cells using 4-hydroperoxycyclophosphamide.

J. Nolta, R. Parkman, M. Ozkaynak, 1990, Cancer research.

Efficient Generation of Induced Pluripotent Stem and Neural Progenitor Cells From Acutely Harvested Dura Mater Obtained During Ventriculoperitoneal Shunt Surgery.

B. Waldau, J. Nolta, G. Bauer, 2015, World neurosurgery.

Highly Efficient Differentiation of Functional Hepatocytes From Human Induced Pluripotent Stem Cells

Jeannine McGee, M. Zern, V. Tolstikov, 2013, Stem cells translational medicine.

Toward gene therapy for Gaucher disease.

G. Crooks, D. Kohn, J. Nolta, 1991, Human gene therapy.

Signaling defects in iPSC-derived fragile X premutation neurons.

P. Hagerman, R. Hagerman, I. Pessah, 2012, Human molecular genetics.

Specific Transduction of HIV-Susceptible Cells for CCR5 Knockdown and Resistance to HIV Infection: A Novel Method for Targeted Gene Therapy and Intracellular Immunization

J. Nolta, G. Bauer, Joseph S Anderson, 2009, Journal of acquired immune deficiency syndromes.

Preclinical translation of exosomes derived from mesenchymal stem/stromal cells

F. Elahi, J. Nolta, D. Farwell, 2019, Stem Cells (Dayton, Ohio).

Self-inactivating lentiviral vectors resist proviral methylation but do not confer position-independent expression in hematopoietic stem cells.

E. Richard, F. Moreau-Gaudry, P. Malik, 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

Gene therapy for adenosine deaminase deficiency.

K. Weinberg, G. Crooks, D. Kohn, 2000, Annual review of medicine.

Mesenchymal stem cell-based therapy for ischemic stroke

O. Fiehn, F. Chédin, J. Lehtiö, 2016, Chinese Neurosurgical Journal.

Long-Term Hematopoiesis in Immune-Deficient Mice After Ex Vivo Progenitors to Sustain + FLT3 Ligand Preserves the Ability of Human CD34

C. Hannum, D. Kohn, J. Nolta, 2012 .

15 – Haematopoietic stem cells for gene therapy

D. Kohn, J. Nolta, 1997 .

Clonal diversity of primitive human hematopoietic progenitors following retroviral marking and long-term engraftment in immune-deficient mice.

J. Nolta, M. Dao, X. Yu, 1997, Experimental hematology.

Umbilical cord blood cell transduction by retroviral vectors: preclinical studies to optimize gene transfer.

D. Kohn, J. Nolta, R. Parkman, 1994, Blood cells.

Use of the bnx/hu xenograft model of human hematopoiesis to optimize methods for retroviral-mediated stem cell transduction (Review).

J. Nolta, M. Dao, 1998, International journal of molecular medicine.

The Complex Ethics of First in Human Stem Cell Clinical Trials

J. Nolta, N. Joyce, M. Yarborough, 2012, AJOB neuroscience.

Genetic engineering of mesenchymal stem cells

J. Nolta, 2006 .

Examination of mesenchymal stem cell-mediated RNAi transfer to Huntington's disease affected neuronal cells for reduction of huntingtin

J. Nolta, S. Olson, W. Cary, 2012, Molecular and Cellular Neuroscience.

Genetically Engineered Mesenchymal Stem Cells as a Proposed Therapeutic for Huntington’s Disease

V. Wheelock, J. Nolta, G. Bauer, 2011, Molecular Neurobiology.

Improved MSC Minimal Criteria to Maximize Patient Safety: A Call to Embrace Tissue Factor and Hemocompatibility Assessment of MSC Products

J. Ankrum, J. Nolta, S. Olson, 2022, Stem cells translational medicine.

Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation.

L. Kunkel, J. D. den Dunnen, K. Weinberg, 2002, The Journal of clinical investigation.

Role of miRNAs in Neuronal Differentiation from Human Embryonic Stem Cell—Derived Neural Stem Cells

Kasia Wilczek, J. Nolta, B. McLaughlin, 2012, Stem Cell Reviews and Reports.

Concise Review: Stem Cells in Osteoimmunology

J. Nolta, I. Adamopoulos, F. Fierro, 2017, Stem cells.

Preintegration HIV-1 inhibition by a combination lentiviral vector containing a chimeric TRIM5 alpha protein, a CCR5 shRNA, and a TAR decoy.

J. Nolta, G. Bauer, Joseph S Anderson, 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

Novel murine xenograft model for the evaluation of stem cell therapy for profound dysphagia

P. Belafsky, M. Kuhn, J. Nolta, 2017, The Laryngoscope.

Expression of human glucocerebrosidase following retroviral vector-mediated transduction of murine hematopoietic stem cells.

D. Kohn, J. Nolta, L. Uribe, 1991, Bone marrow transplantation.

Intravitreal autologous bone marrow CD34+ cell therapy for ischemic and degenerative retinal disorders: preliminary phase 1 clinical trial findings.

Robert J Zawadzki, John S Werner, Jan Nolta, 2014, Investigative ophthalmology & visual science.

Leaky ribosomal scanning in mammalian genomes: significance of histone H4 alternative translation in vivo

B. Frenkel, J. Hacia, Mazen W. Karaman, 2005, Nucleic acids research.

Multidrug resistance gene expression in pediatric primitive neuroectodermal tumors of the central nervous system.

K. Weinberg, J. Nolta, C. Raffel, 1992, Journal of neurosurgery.

Genetically Engineered Mesenchymal Stem Cells for Cell and Gene Therapy

J. Nolta, Yunjoon Jung, 2013 .

Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purged marrows for children with acute non-lymphoblastic leukemia in second remission.

K. Weinberg, D. Kohn, J. Nolta, 1990, Bone marrow transplantation.

activity repopulating cells isolated according to aldehyde dehydrogenase Functional characterization of highly purified human hematopoietic

J. Nolta, T. Meyerrose, D. Hess, 2013 .

Contribution of human hematopoietic stem cells to liver repair

J. Nolta, P. Zhou, G. Annett, 2009, Seminars in Immunopathology.

Recent advances in hematopoietic stem cell biology

J. Nolta, J. Bonde, D. Hess, 2004, Current opinion in hematology.

Exosomes Derived from Human Primed Mesenchymal Stem Cells Induce Mitosis and Potentiate Growth Factor Secretion

P. Belafsky, Brian Fury, J. Nolta, 2019, Stem cells and development.

Reversing bone loss by directing mesenchymal stem cells to bone

David J. Olivos, R. Ritchie, N. Lane, 2013, Stem cells.

Nanoparticle targeted therapy against childhood acute lymphoblastic leukemia

Kit Lam, Kai Xiao, Joyce Lee, 2011, Defense + Commercial Sensing.

Induction of Human Embryonic and Induced Pluripotent Stem Cells Into Urothelium

J. Nolta, E. Kurzrock, A. Luria, 2014, Stem cells translational medicine.

Albumin-expressing hepatocyte-like cells develop in the livers of immune-deficient mice that received transplants of highly purified human hematopoietic stem cells.

George McNamara, Xiuli Wang, G. McNamara, 2003, Blood.

Feasibility Study of Canine Epidermal Neural Crest Stem Cell Transplantation in the Spinal Cords of Dogs

T. Garcia, S. Sisó, J. Nolta, 2015, Stem cells translational medicine.

Stem Cells in Canine Spinal Cord Injury – Promise for Regenerative Therapy in a Large Animal Model of Human Disease

J. Nolta, D. Borjesson, B. Sturges, 2015, Stem Cell Reviews and Reports.

Concise Review: Human Dermis as an Autologous Source of Stem Cells for Tissue Engineering and Regenerative Medicine

Jerry C. Hu, N. Vapniarsky, K. Athanasiou, 2015, Stem cells translational medicine.

Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models

V. Wheelock, Brian Fury, J. Nolta, 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

Title Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington ' s Disease Mouse Models

V. Wheelock, Brian Fury, J. Nolta, 2016 .

AN INCREASE IN THE LEVELS OF RETROVIRAL-MEDIATED TRANSDUCTION OF ENGRAFTING HUMAN HEMATOPOIETIC PROGENITORS CAN BE OBTAINED BY MANIPULATION OF THE HEMATOPOIETIC CELL CYCLE

J. Nolta, M. Dao, 1999 .

Clinical translation of stem cells: insight for cartilage therapies

Jerry C. Hu, Kyriacos A Athanasiou, Jerry C Hu, 2014, Critical reviews in biotechnology.

J. Nolta, W. Cary, Dayita Biswas, 2020, International journal of molecular sciences.

A novel Huntington's disease mouse model to assess the role of neuroinflammation on disease progression and to develop human cell therapies

J. Nolta, Joseph S Anderson, W. Cary, 2021, Stem cells translational medicine.

A Pilot Study Evaluating the Safety and Efficacy of AMD3100 for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Patients with Advanced Hematological Malignancies.

R. Vij, D. Link, J. Dipersio, 2004 .

Mesenchymal Stem Cells Respond to Hypoxia by Increasing Diacylglycerols

B. Merkely, J. Nolta, F. Fierro, 2016, Journal of cellular biochemistry.

IL-7 Enhances the Responsiveness of Human T Cells That Develop in the Bone Marrow of Athymic Mice1

K. Weinberg, Xiuli Wang, J. Nolta, 2001, The Journal of Immunology.

Inclusion of IL-3 during retrovirally-mediated transduction on stromal support does not increase the extent of gene transfer into long-term engrafting human hematopoietic progenitors.

J. Nolta, M. Dao, 1997, Cytokines, cellular & molecular therapy.

Liver Engraftment by Transplanted Human Progenitor Cells with High Aldehyde Dehydrogenase Activity in a Novel Model, NOD/SCID/MPSVII Mice.

P. Zhou, J. Nolta, D. Hess, 2007 .

2203

J. Nolta, J. Beegle, Joseph S Anderson, 2017, Journal of Clinical and Translational Science.

Clinical trial perspective for adult and juvenile Huntington's disease using genetically-engineered mesenchymal stem cells

J. Nolta, G. Annett, K. Fink, 2016, Neural regeneration research.

Insulin and igfs enhance hepatocyte differentiation from human embryonic stem cells via the PI3K/AKT pathway

M. Zern, J. Nolta, P. Zhou, 2013, Stem cells.

Advances in bone marrow stem cell therapy for retinal dysfunction

R. Zawadzki, J. Werner, E. Moisseiev, 2017, Progress in Retinal and Eye Research.

Clinical Infection Control in Gene Therapy: A Multidisciplinary Conference

J. Gerberding, J. Nolta, H. Kaufman, 2000, Infection Control & Hospital Epidemiology.

Molecular mechanism of transforming growth factor b – mediated cell-cycle modulation in primary human CD 34 1 progenitors

J. Nolta, M. Dao, Joseph Hwa, 2001 .

Guided Migration of Neural Stem Cells Derived from Human Embryonic Stem Cells by an Electric Field

Min Zhao, Jing Liu, Lei Zhang, 2012, Stem cells.

Characterization and in vivo testing of mesenchymal stem cells derived from human embryonic stem cells.

J. Nolta, S. Olson, Amal Kambal, 2011, Tissue engineering. Part A.

Allele-Specific Reduction of the Mutant Huntingtin Allele Using Transcription Activator-Like Effectors in Human Huntington's Disease Fibroblasts

V. Wheelock, D. Segal, J. Nolta, 2016, Cell transplantation.

Concise Review: MicroRNA Function in Multipotent Mesenchymal Stromal Cells

J. Nolta, Jan A Nolta, Elizabeth A Clark, 2014, Stem cells.

Combination product of dermal matrix, preconditioned human mesenchymal stem cells and timolol promotes wound healing in the porcine wound model.

J. Nolta, E. Kurzrock, A. Soulika, 2022, Journal of biomedical materials research. Part B, Applied biomaterials.

A pilot study evaluating the safety and efficacy of AMD3100 for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells in patients with advanced hematological malignancies

D. Link, J. Dipersio, J. Nolta, 2005 .

Human progenitor cells with high aldehyde dehydrogenase activity efficiently engraft into damaged liver in a novel model

J. Nolta, P. Zhou, D. Hess, 2009, Hepatology.

Small Animal Models of Tissue Regeneration

J. Nolta, C. Yellowley, H. Machens, 2011 .

Role of MEF2C in the Endothelial Cells Derived from Human Induced Pluripotent Stem Cells.

Aijun Wang, J. Nolta, A. Kim, 2023, Stem cells.

Keynote address—Working Toward Mesenchymal Stem Cell Therapy for HD

J. Nolta, 2010 .

Canine Epidermal Neural Crest Stem Cells: Characterization and Potential as Therapy Candidate for a Large Animal Model of Spinal Cord Injury

J. Nolta, D. Borjesson, M. Sieber-Blum, 2014, Stem cells translational medicine.

Intracranial alternating current stimulation facilitates neurogenesis in a mouse model of Alzheimer’s disease

Theodore P. Zanto, T. Zanto, Weijian Yang, 2020, Alzheimer's Research & Therapy.

Developing stem cell therapies for juvenile and adult-onset Huntington’s disease

V. Wheelock, J. Nolta, G. Annett, 2015, Regenerative medicine.

Making Heads or Tails of the Large Mammalian Sinoatrial Node Micro-Organization.

D. Lieu, J. Nolta, J. Chan, 2021, Circulation. Arrhythmia and electrophysiology.

Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models.

V. Wheelock, Brian Fury, J. Nolta, 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

Potential long-term treatment of hemophilia A by neonatal co-transplantation of cord blood-derived endothelial colony-forming cells and placental mesenchymal stromal cells

Aijun Wang, J. Nolta, P. Zhou, 2019, Stem Cell Research & Therapy.

Mesenchymal stem cells ameliorate inflammation in an experimental model of Crohn’s disease via the mesentery

M. Dave, F. Cominelli, J. Nolta, 2023, bioRxiv.

2 Enhanced angiogenesis as a target for tumor therapy

J. Nolta, 2013 .

Mesenchymal stem cells as a carrier for tumor-targeting therapeutics

J. Nolta, Jian Wu, A. Chang, 2013 .

The age of immunotherapy—Celebrating STEM CELLS' contribution to understanding mechanisms of immune system development and modulation

J. Nolta, 2019, Stem cells.

Natural Killer Cell Subsets Differentially Reject Embryonic Stem Cells Based on Licensing

J. Nolta, W. Murphy, E. Ames, 2014, Transplantation.

Now More Than Ever: The Importance of Reporting Evidence‐Based Science

J. Nolta, 2018, Stem Cells.

Inosculation of blood vessels allows early perfusion and vitality of bladder grafts--implications for bioengineered bladder wall.

J. Nolta, E. Kurzrock, M. So, 2015, Tissue engineering. Part A.

Preclinical evaluation of mesenchymal stem cells overexpressing VEGF to treat critical limb ischemia

J. Nolta, P. Zhou, G. Annett, 2016, Molecular therapy. Methods & clinical development.

Animal xenograft models for evaluation of gene transfer into human hematopoietic stem cells.

J. Nolta, M. Dao, E. Tsark, 1999, Current opinion in molecular therapeutics.

Extrathymic human t lymphocyte development and regulation in immune deficient mice

J. Nolta, R. Hong, X. Wang, 2000 .

Research Leads to Approved Therapies in the New Era of Living Medicine

J. Nolta, 2018, Stem cells.

Human thymus mesenchymal stromal cells augment force production in self-organized cardiac tissue.

C. Hodonsky, J. Nolta, E. Bove, 2010, The Annals of thoracic surgery.

Molecular targeting in childhood malignancies using nanoparticles

Kit Lam, Nitin Nitin, Noriko Satake, 2012, Defense, Security, and Sensing.

Role of miRNAs in Neuronal Differentiation from Human Embryonic Stem Cell—Derived Neural Stem Cells

Kasia Wilczek, J. Nolta, B. McLaughlin, 2012, Stem Cell Reviews and Reports.

HDACs regulate the differentiation of endothelial cells from human iPSCs

J. Nolta, A. Kim, Tao Li, 2022, Cell Biochemistry and Function.

Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells.

J. Nolta, M. Creer, W. Eades, 2006, Blood.

An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells (MSC) Committee perspectives on International Standards Organization/Technical Committee 276 Biobanking Standards for bone marrow-MSCs and umbilical cord tissue-derived MSCs for research purposes.

K. Tarte, M. Lalu, Georges Dagher, 2023, Cytotherapy.

Computational Analysis of Contractility in Engineered Heart Tissue

William Childs, Jan Nolta, Grant Mathews, 2012, IEEE Transactions on Biomedical Engineering.

Human CD34+Cells Mobilized by AMD3100 Demonstrate Enhanced NOD/SCID Repopulating Function Compared to CD34+ Cells Mobilized by Granulocyte Colony Stimulating Factor.

J. Dipersio, J. Nolta, S. Devine, 2005 .

Molecular mechanism of transforming growth factor beta-mediated cell-cycle modulation in primary human CD34(+) progenitors.

J. Nolta, M. Dao, Joseph Hwa, 2002, Blood.

Clinical translation of stem cells: insight for cartilage therapies

Jerry C. Hu, K. Athanasiou, J. Nolta, 2014, Critical Reviews in Biotechnology.

shRNA-mediated decreases in c-Met levels affect the differentiation potential of human mesenchymal stem cells and reduce their capacity for tissue repair.

D. Link, J. Nolta, Ivana Rosová, 2010, Tissue engineering. Part A.

Hypoxic Preconditioning Results in Increased Motility and Improved Therapeutic Potential of Human Mesenchymal Stem Cells

D. Link, J. Nolta, Benjamin J. Capoccia, 2008, Stem cells.

Editorial: 2013—A Year of Clinical Success and Great Scientific Innovation in the Stem Cell Field

J. Nolta, 2014, Stem cells.

Guided Migration of Neural Stem Cells Derived from Human Embryonic Stem Cells by an Electric Field

Min Zhao, J. Nolta, Lei Zhang, 2012, Stem cells.

Mesenchymal stem cells for the treatment of neurodegenerative disease.

J. Nolta, G. Bauer, N. Joyce, 2010, Regenerative medicine.

Immune-deficient mouse models for analysis of human stem cells.

J. Nolta, T. Meyerrose, D. Hess, 2003, BioTechniques.

Generation of an HIV-1-Resistant Immune System with CD34+ Hematopoietic Stem Cells Transduced with a Triple-Combination Anti-HIV Lentiviral Vector

R. Pollard, J. Nolta, G. Bauer, 2012, Journal of Virology.

Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells.

J. Nolta, M. Creer, L. Wirthlin, 2006, Blood.

In vivo biosafety model to assess the risk of adverse events from retroviral and lentiviral vectors.

Xiuli Wang, S. S. Case, D. Kohn, 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

Examination of mesenchymal stem cell-mediated RNAi transfer to Huntington's disease affected neuronal cells for reduction of huntingtin

J. Nolta, S. Olson, W. Cary, 2012, Molecular and Cellular Neuroscience.

Genetically Engineered Mesenchymal Stem Cells as a Proposed Therapeutic for Huntington’s Disease

V. Wheelock, J. Nolta, G. Bauer, 2011, Molecular Neurobiology.

Loss of MXD3 induces apoptosis of Reh human precursor B acute lymphoblastic leukemia cells.

K. Lam, N. Satake, J. Nolta, 2015, Blood cells, molecules & diseases.

Retroviral mediated transfer of the cDNA for human glucocerebrosidase into hematopoietic stem cells of patients with Gaucher disease. A phase I study.

C. Dunbar, D. Kohn, J. Nolta, 1996, Human gene therapy.

Autoimmune T cells lured to a FASL web of death by MSCs.

J. Nolta, W. Murphy, 2012, Cell stem cell.

Research Leads to Approved Therapies in the New Era of Living Medicine

J. Nolta, 2018, Stem cells.

The Complex Ethics of First in Human Stem Cell Clinical Trials

J. Nolta, N. Joyce, M. Yarborough, 2012, AJOB neuroscience.

Working Toward Better Tissue Repair Therapies: Exposure of MSC to Hypoxic Conditions In Vitro Increases Levels of the Hepatocyte Growth Factor Receptor c-met, Improves Motility, and Induces Phosphorylation of the Pro-Survival Protein AKT.

J. Nolta, T. Meyerrose, Ivana Rosová, 2005 .